What medtech manufacturing capabilities does Knowles (KN) highlight related to the Elucent Medical agreement?

Knowles highlights precision capabilities such as micro coiling, molding, stamping, cable assembly, and precision machining. According to Knowles, these vertically integrated services, combined with engineering support, are positioned as well-suited for medtech applications like Elucent Medical’s smart surgical guidance device and related miniaturized solutions.

Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Positive)

Rhea-AI Summary

Knowles (NYSE: KN) announced an agreement to manufacture Elucent Medical's smart surgical guidance device used with Elucent's EnVisio In-Body Spatial Intelligence System. Knowles was selected for its micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to support device design, development, and launch.

According to Knowles, its teams collaborated closely with Elucent to iterate designs, improve tolerances and materials, and enhance production readiness, quality, scalability, and time-to-market. Manufacturing is conducted at an ISO 13485-certified and FDA-registered Knowles facility in Penang, Malaysia, leveraging a broad medtech-focused precision manufacturing portfolio.

Positive

Manufacturing agreement with Elucent Medical to produce smart surgical guidance device
ISO 13485-certified, FDA-registered facility in Penang supports medtech production
Design-for-manufacturability collaboration improved production readiness, quality, and scalability
Process optimization reduced time to market and sourced cost-effective materials

Negative

None.

Market Context

KN's Q1 2026 earnings announcement produced a recorded -2.11% 24-hour reaction despite positive repo...

Analysis

KN's Q1 2026 earnings announcement produced a recorded -2.11% 24-hour reaction despite positive reported results. The current manufacturing agreement adds operational context, while recent net insider selling remains a risk factor.

Key Figures

Announcement Date: August 12, 2026 Facility Certification: ISO 13485

2 metrics

Announcement Date August 12, 2026 Knowles manufacturing agreement announcement

Facility Certification ISO 13485 Knowles facility in Penang, Malaysia

Historical Context

5 past events · Latest: Jul 23 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 23	Q2 earnings report	Positive	-3.2%	Revenue, EPS, margins, and full-year guidance improved, yet the 24-hour reaction was negative.
Jul 01	Earnings date announcement	Neutral	-2.3%	The company scheduled second-quarter results and its investor conference call, followed by a negative reaction.
Apr 23	Q1 earnings report	Positive	-2.1%	Quarterly revenue, EPS, and gross margin increased, while the 24-hour reaction was negative.
Apr 13	Conference participation	Neutral	+0.3%	Knowles announced participation in two investor conferences, followed by a slightly positive reaction.
Mar 31	Earnings date announcement	Neutral	+4.5%	The company scheduled first-quarter results and a conference call, followed by a positive reaction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The recorded positive earnings announcements were followed by negative 24-hour price reactions, indicating repeated divergence between news direction and market response.

Key Terms

micro molding, design-for-manufacturability, iso 13485, fda-registered

4 terms

micro molding technical

"Knowles for micro molding capabilities, design-for-manufacturability expertise"

Micro molding is a precision manufacturing process that produces very small, detailed plastic or metal parts using specialized molds and high-precision injection or compression techniques. It matters to investors because the capability affects product quality, production cost, yield and the ability to scale supply for industries that need tiny components—think of it like a high-resolution printer that must reliably make thousands of identical miniature parts.

design-for-manufacturability technical

"using a design-for-manufacturability (DFM) optimization approach"

Design-for-manufacturability is the practice of shaping a product’s design so it can be made reliably, quickly and cheaply at scale. For investors, it matters because a design that’s easy to manufacture reduces production delays, lowers costs and improves quality consistency—similar to choosing a simple recipe that yields the same cake every time rather than a complicated one that often fails. Products designed this way are more likely to hit revenue targets and protect profit margins.

iso 13485 regulatory

"one of Knowles' ISO 13485-certified and FDA-registered facilities"

ISO 13485 is an international quality management standard for organizations that design, produce, or service medical devices. Think of it as a factory’s rulebook and checklist that helps ensure products are safe, consistently made, and meet regulatory rules worldwide. For investors, certification signals lower operational and regulatory risk, easier market access, and greater reliability of a company’s medical products and supply chain — similar to buying from a trusted, inspected supplier.

fda-registered regulatory

"ISO 13485-certified and FDA-registered facilities in Penang, Malaysia"

An FDA-registered facility or product is one that has been listed with the U.S. Food and Drug Administration as required for certain medical devices, manufacturers, or establishments — like being entered in an official government directory. It does not mean the FDA has approved or certified safety or effectiveness, but it does mean the operation is subject to inspections and regulatory rules, which affects market access, investor risk assessment, and credibility with customers and partners.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/12/2026 - 08:04 AM

Elucent chooses Knowles for micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to accelerate production of their critical surgical guidance device.

ITASCA, Ill., Aug. 12, 2026 /PRNewswire/ -- Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high-performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature (BA) speakers, today announced an agreement to produce Elucent Medical's smart surgical guidance device for use with its EnVisio^® In-Body Spatial Intelligence^TM System.

Knowles will produce Elucent Medical’s smart surgical guidance device for use with its EnVisio® In-Body Spatial IntelligenceTM System.

Leveraging Knowles' micro molding capabilities and using a design-for-manufacturability (DFM) optimization approach, Knowles worked with Elucent to iterate designs, identify tolerance and material improvement opportunities, and provide guidance throughout product design, development, and launch of their surgical guidance device.

"Knowles stands out as a technically capable, highly engaged, and future-focused partner," said Jeremy Klem, Vice President of Operations for Elucent Medical. "By combining deep engineering expertise, uncompromising quality, speed, and cost efficiency, Knowles enabled us to bring an excellent product to market faster and with greater confidence."

By focusing on manufacturability and continuous improvement, Knowles:

Improved production readiness, quality, and scalability
Sourced cost-effective materials
Reduced time to market
Built a foundation for future product improvement

This approach led to a more manufacturable, reliable product that is produced at one of Knowles' ISO 13485-certified and FDA-registered facilities in Penang, Malaysia.

"Our teams worked hands-on with Elucent Medical engineers at every stage, offering proactive input on design, performance, cost, and reliability," said Jon Kiachian, President of MedTech and Specialty Audio at Knowles Corporation. "Our outcome-focused problem-solving approach is what makes Knowles the right long-term manufacturing partner."

Knowles offers a wide array of precision manufacturing capabilities ideal for the MedTech market, including micro coiling, molding, stamping, cable assembly, and precision machining.

For more information, visit https://www.knowles.com/products/custom-solutions/medtech-miniaturization.

About Knowles

Knowles is a leading manufacturer of specialty electronic components. We design parts that perform unique, critical functions for innovative technologies. Through extreme reliability, custom engineering, and scalable manufacturing, we enable businesses to succeed in the most demanding applications across MedTech, Defense, and Industrial markets.

Our high-performance capacitors, RF/Microwave filters, advanced medtech microphones, balanced armatures, and miniaturization products enable and enhance the performance of technologies with the power to change, improve, and save lives. Founded in 1946 and headquartered in Itasca, Illinois, Knowles has grown into a global organization with employees spanning 11 countries.

For more information, visit https://www.knowles.com.

About Elucent Medical

Elucent Medical is a leading innovator in guided surgical technologies, dedicated to improving patient outcomes through precision and accuracy. EnVisio® and SmartClip® provide advanced soft-tissue localization and surgical guidance powered by In-Body Spatial Intelligence™. Through a commitment to innovation and collaboration, Elucent Medical is advancing precision in soft tissue surgery and making a meaningful impact on patients and the medical professionals who care for them. For more information about Elucent Medical and its innovative technologies,

please, visit https://www.elucent.com.

Media Contact

Jamie Tokarz
Jamie@trewmarketing.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/elucent-medical-selects-knowles-corporation-to-manufacture-advanced-surgical-guidance-device-302849118.html

SOURCE Knowles Corporation

FAQ

What did Knowles (NYSE: KN) announce with Elucent Medical on August 12, 2026?

Knowles announced an agreement to manufacture Elucent Medical’s smart surgical guidance device. According to Knowles, the device is used with Elucent’s EnVisio In-Body Spatial Intelligence System and benefits from Knowles’ micro molding, design-for-manufacturability expertise, and vertically integrated assembly for development and production.

Why did Elucent Medical select Knowles (KN) to manufacture its smart surgical guidance device?

Elucent selected Knowles for micro molding capabilities, design-for-manufacturability focus, and vertically integrated assembly. According to Knowles, the collaboration helped iterate designs, improve tolerances and material choices, enhance production readiness and scalability, and support faster, more confident market launch of the surgical guidance device.

Where will Knowles manufacture Elucent Medical’s surgical guidance device and what certifications support it?

Knowles will produce the device at its facility in Penang, Malaysia. According to Knowles, this site is ISO 13485-certified and FDA-registered, supporting regulated medtech manufacturing and providing a foundation for reliable, scalable production of Elucent Medical’s smart surgical guidance product.

How does Knowles’ design-for-manufacturability approach benefit the Elucent Medical guidance device?

Knowles’ design-for-manufacturability approach improves manufacturability, reliability, and cost efficiency for the device. According to Knowles, teams worked hands-on with Elucent engineers to refine designs, improve materials, enhance quality and scalability, reduce time to market, and build a platform for future product improvements.